	Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial. Nat Commun Orme JJ, Zhang H, Lingamaneni P, Kim Y, Lavoie R, Dorr M, Dizona P, Hirdler J, Bering EA, Gicobi JK, Hsu M, Dale H, Childs DS, Kottschade LA, McWilliams RR, Block MS, Mansfield AS, Markovic SN, Olivier K, Owen D, Lester S, Ma D, Dronca RS, Dong H, Lucien F, Packard AT, Winters JL, Park SS. PMID: 40082438 [PubMed - indexed for MEDLINE]
	BTLA promoter hypomethylation correlates with enhanced immune cell infiltration, favorable prognosis, and immunotherapy response in melanoma. J Immunother Cancer Yang M, Zheng C, Miao Y, Yin C, Tang L, Zhang C, Yu P, Han Q, Ma Y, Li S, Jiang G, Li W, Xia P. PMID: 40081944 [PubMed - indexed for MEDLINE]
	Estudio prospectivo multicÃ©ntrico de casos y controles del exposoma en melanoma. Actas Dermosifiliogr Navarro-Bielsa A, Gracia-Cazaña T, Almagro M, De-la-Fuente-Meira S, Florez Á, Yélamos O, Montero-Vilchez T, González-Cruz C, Diago A, Abadías-Granado I, Fuentelsaz V, Colmenero M, Bañuls J, Arias-Santiago S, Buendía-Eisman A, Almenara-Blasco M, Gil-Pallares P, Gilaberte Y. PMID: 40081473 [PubMed - as supplied by publisher]
	Novel treatment vs. standard of care in melanoma-associated leptomeningeal metastases: a systematic review and network meta-analysis. Chin Clin Oncol Teo JJ, Chauhan A, Nossier R, Tan TZ, Nga VDW. PMID: 40081385 [PubMed - indexed for MEDLINE]
	Microvascular changes after proton beam radiotherapy for iris melanoma: An optical coherence tomography angiography study. Eur J Ophthalmol Fallico M, Longo A, Avitabile T, Alosi P, Dammino E, Reibaldi M, Marolo P, Parisi G, Castellino N, Bonfiglio V, Caltabiano R, Broggi G, Foti P, Spatola C, Ragusa M, Barbagallo C, Borrelli E, Russo A. PMID: 40080844 [PubMed - as supplied by publisher]
	Surgical management of oligometastatic recurrence in primary esophageal melanoma: a feasible approach in resource-limited settings. J Surg Case Rep Kondratskyi Y, Pepenin M, Horodetskyi A, Dobrzhanskyi O, Kolesnyk A, Shudrak Y, Krotevych M. PMID: 40079041 [PubMed]
	Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAF(V600)-mutant melanoma in Spain: the BECARE (GEM-2002) trial. Front Oncol Soria A, Sanchez Mauriño P, Serrano Domingo JJ, García Galindo R, Sequero S, Gutiérrez Sanz L, Crespo G, Díaz-Beveridge R, Puértolas T, López P, Fra Rodríguez J, López Castro R, Aguayo C, Valdivia J, Cunquero-Tomás AJ, Benítez G, Ayala de Miguel P, Espinosa E, Muñoz-Couselo E, Campos B, García Sánchez L, Cerezuela-Fuentes P. PMID: 40078188 [PubMed]
	Unravelling the Regulatory Roles of lncRNAs in Melanoma: From Mechanistic Insights to Target Selection. Int J Mol Sci Moras B, Sissi C. PMID: 40076754 [PubMed - indexed for MEDLINE]
	DIA/SWATH-Mass Spectrometry Revealing Melanoma Cell Proteome Transformations with Silver Nanoparticles: An Innovative Comparative Study. Int J Mol Sci Martano S, Faktor J, Kote S, Cascione M, Di Corato R, Faktorova D, Semeraro P, Rizzello L, Leporatti S, Rinaldi R, De Matteis V. PMID: 40076651 [PubMed - indexed for MEDLINE]
	Melanoma Arising in Tattoos: A Case Series and Scoping Review of the Literature. Cancers (Basel) Brusasco M, Spagnolini S, Mazzoni L, Magi S, Scarcella G, Stanganelli I. PMID: 40075615 [PubMed]
	AI Model for Predicting Anti-PD1 Response in Melanoma Using Multi-Omics Biomarkers. Cancers (Basel) Gschwind A, Ossowski S. PMID: 40075562 [PubMed]
	Screening for cognitive impairment in routine clinical oncology practice: a pilot study using patient-reported outcome measures and online cognitive testing in melanoma and breast cancer patients. Support Care Cancer Albers EAC, de Ligt KM, van der Ploeg IMC, Wouters MJWM, Schagen SB, van de Poll-Franse LV. PMID: 40074888 [PubMed - indexed for MEDLINE]
	In-transit melanoma metastases: Evaluation and Management for the Dermatologist. J Am Acad Dermatol Kumar AB, Jakub JW, Lester SC, Markovic SN, Baum CL. PMID: 40074149 [PubMed - as supplied by publisher]
	Novel Clinical PET Tracers in the Pipeline for Melanoma. Curr Oncol Rep Jaber N, Saadani H, Schats W, Aalbersberg EA, Stokkel MPM. PMID: 40072700 [PubMed - as supplied by publisher]
	Can AI models assist patients in screening for non-melanoma skin cancer? Evaluating diagnostic accuracy of ChatGPT and Gemini using clinical images. Arch Dermatol Res Modiri O, Ebriani J, Davis J. PMID: 40072644 [PubMed - in process]
	Risk Prediction Models for Sentinel Node Positivity in Melanoma: A Systematic Review and Meta-Analysis. JAMA Dermatol Ma B, Gandhi M, Czyz S, Jia J, Rankin B, Osman S, Jonsson EL, Robertson L, Parsons L, Temple-Oberle C. PMID: 40072444 [PubMed - as supplied by publisher]
	Pre-clinical Safety Study of Cold Atmospheric Plasma (CAP) Produced by an Inbuilt CAP Device and ROS Mediated Apoptotic Activity in Human Skin Melanoma Cells. Curr Pharm Des Chakraborty R, Gohain RB, Talukdar P, Changkakoti L, Biswas S, Mukherjee AK, Bala A. PMID: 40070328 [PubMed - as supplied by publisher]
	Overexpression of LMOD1 induces oxidative stress and enhances cell apoptosis of melanoma through the RIG-I like receptor pathway. Biochim Biophys Acta Mol Basis Dis Lei H, Huang L, Wan H, Chen M. PMID: 40068386 [PubMed - as supplied by publisher]
	Comparing the number-needed-to-biopsy ratio for melanoma diagnosis forÂ artificial intelligence as a medical device, teledermatology and face-to-face models of care. Clin Exp Dermatol Bali R, Chung JG, Thomas L, Hussain K, Fearfield L. PMID: 40067998 [PubMed - as supplied by publisher]
	The Landmark Series: Melanoma and Adjuvant Therapy. Ann Surg Oncol Lowe MC, Delman KA, Ollila DW. PMID: 40067605 [PubMed - as supplied by publisher]

Articles 1 - 20 / 42401

Page 1 of 2121



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy